Meeting Brochure and registration form      SMDM Homepage

Monday, October 22, 2007: 7:00 AM-8:30 AM
Grand Station III, IV, V (Sheraton Station Square Hotel)
Poster Session II
*KNOWLEDGE AND ATTITUDES OF YOUNG ADULTS CONCERNING END-OF-LIFE DECISION-MAKING
Dionysios Kavalieratos, Teresa Orkoskey, BS, Howard Degenholtz, PhD, David Barnard, JD, PhD
THE COST EFFECTIVENESS OF INTERFERON-γ RELEASE ASSAYS VS. TUBERCULIN SKIN TESTS FOR DETECTING LATENT TUBERCULOSIS INFECTION IN HEALTHCARE WORKERS
Marie A. DePerio, MD, Joel Tsevat, MD, MPH, Stephen Kralovic, MD, MPH, Gary Roselle, Mark Eckman, MD, MS
*HOW LONG DO MENOPAUSAL SYMPTOMS LAST? A SEQUENTIAL META ANALYSIS
Mary C. Politi, PhD, Mark D. Schleinitz, MD, MS, Nananda F. Col, MD, MPH, MPP
USE OF ANALYTIC HIERARCHY PROCESS TO IMPROVE DECISION MAKING IN ANKLE FOOT DEFORMITIES AFTER STROKE
Maarten J. IJzerman, PhD, Janine A. van Til, James G. Dolan, MD, Gerbert J. Renzenbrink
*NECK PAIN PATIENTS' EVALUATIVE SCORES FOR THEIR CURRENT HEALTH
Gabrielle van der Velde, PhD, (candidate), Hilary A. Llewellyn-Thomas, PhD, Sheilah Hogg-Johnson, PhD, Eric Hurwitz, DC, PhD, J.David Cassidy, DC, PhD, Pierre Cote, DC, PhD, M. Krahn, MD, MSc
TOWARDS A BETTER UNDERSTANDING OF THE EVPI MEASURE
H. Koffijberg, M. P. Janssen
ERECTILE DYSFUNCTION AND MENTAL HEALTH IN AGEING MALES
Ida J. Korfage, PhD, Saskia M.F. Pluijm, PhD, Monique Roobol, PhD, Marie-Louise Essink-Bot, MD, PhD
COST-EFFECTIVENESS OF ADDING THE SERUM CDT TEST TO QUESTIONNAIRE BASED SCREENING FOR UNHEALTHY ALCOHOL USE IN THE PRIMARY CARE SETTING
Alok Kapoor, MD, MSc, Kevin L. Kraemer, MD, MSc, Kenneth Smith, MD, MS, Mark S. Roberts, MD, MPP, Rich Saitz, MD, MPH
A NATIONAL INTERNET-BASED SURVEY OF HEALTH VALUES FOR CEREBRAL ANEURYSMS
Joseph T. King Jr., MD, MSCE, Cynthia A. Brandt, MD, MPH, Joel Tsevat, MD, MPH, Mark S. Roberts, MD
FACTORS INFLUENCING ELDERLY WOMEN'S MAMMOGRAPHY SCREENING DECISIONS: IMPLICATIONS FOR COUNSELING
Mara Schonberg, MD, MPH, Ellen P. McCarthy, PhD, MPH, Roger B. Davis, Edward R. Marcantonio
THE RELATIONSHIP BETWEEN CANCER SCREENING AND AGE IN THE U.S. AND EUROPE
David H. Howard, PhD, Kenneth Thorpe, PhD, Lisa Richardson, MD
*RECEIVER OPERATING CHARACTERISTIC (ROC) CURVES VERSUS PRECISION-RECALL (PR) CURVES IN MODELS EVALUATED WITH UNBALANCED DATA
Jagpreet Chhatwal, MS, Elizabeth S. Burnside, MD, MPH, MS, Oguzhan Alagoz, PhD
*DEVELOPMENT OF A VISION SPECIFIC UTILITIES ELICITATION METHOD
Leslie McIntosh, MPH, Steven M. Kymes, Ph.D., Brian Perron, Ph.D., M. Carolyn Baum, Ph.D., Robert F. Nease, Jr, PhD, Walton Sumner, M.D.
*A DECISION MAKING RULE FOR MILD HEAD INJURY IN VERY YOUNG CHILDREN
Jeanine M. Buchanich, MEd, MPH, Noel S. Zuckerbraun, MD, Thomas J. Songer, PhD, Barbara A. Gaines, MD
CONTENT VALIDITY OF HEALTH STATE DESCRIPTIONS – SHOULD WE CARE?
Ken Stein, MB, ChB, MSc, FF, Ruairidh Milne, BA, MB, ChB, MSc, Tania Crabb, Matthew Dyer, Julie Ratcliffe, PhD, John Brazier
FACTORS ASSOCIATED WITH THE CHOICE BETWEEN RISK-REDUCING SALPINGO-OOPHORECTOMY (RRSO) AND OVARIAN CANCER SCREENING (OCS) IN WOMEN AT INCREASED GENETIC RISK OF OVARIAN CANCER
Paul K. J. Han, MD, MA, MPH, Richard P. Moser, PhD, Marion Piedmonte, MS, Martee L. Hensley, MD, Michael Stefanek, PhD, Mark H. Greene, MD
ABILITY TO INTERPRET STATEMENTS OF NUMERIC RISK AND PATIENT SATISFACTION WITH ANTI-RHEUMATIC RISK COMMUNICATION
Richard W. Martin, M.D., M.A., Andrew H. Head, M.D., Nicholas K Kuzera, Margaret Holmes-Rovner, PhD
COMPUTATION OF COST AND EFFECTIVENESS IN DECISION TREES WITH EMBEDDED DECISION NODES
Manuel Arias, BS, Francisco J. Díez, PhD
PHARMACOGENETIC TESTING FOR UGT1A1 PRIOR TO IRINOTECAN ADMINISTRATION FOR METASTATIC COLORECTAL CANCER: A COST-UTILITY ANALYSIS
Heather Taffet Gold, PhD, Michael J. Hall, MD, Victoria Blinder, MD, Bruce R. Schackman
SUPERIOR ACCURACY OF COLPOSCOPY IN THE DIAGNOSTIC SETTING COMPARED TO THE SCREENING SETTING
Scott B. Cantor, PhD, Marylou Cardenas-Turanzas, MD, MPH, Dennis D. Cox, PhD, E. Neely Atkinson, Graciela M. Nogueras-Gonzalez, J. Robert Beck, MD, Michele Follen, MD, PhD, J. L. Benedet, MD
*ON DATA QUALITY AND RISK IN GUIDELINE BASED CLINICAL DECISION SUPPORT SYSTEMS
Sharique Hasan, MS, Rema Padman, PhD
COMPETING STRATEGIES FOR DIAGNOSING HELICOBACTER PYLORI INFECTION IN DYSPEPSIA: A COST-EFFECTIVENESS ANALYSIS
Kyland Porter Holmes, BA, MS, John C. Fang, MD, Brian R. Jackson, MS, MD
INCENTIVISING CLINICAL PERFORMANCE: WHEN IS IT WORTHWHILE?
Simon M. Walker, MSc, BA, Anne Mason, Karl Claxton, PhD, MSc, BA, Richard Cookson, Elisabeth A.L. Fenwick, Mark Sculpher, PhD
RELATION BETWEEN HUMAN RESOURCES AND PATIENT SAFETY
Nobuo Koinuma, Sayuri Kaneko, Yasutake Monma, Michiya Ito
*DECISION-MAKING ON CLINICAL OUTCOMES AND PATIENT ASSESSED OUTCOMES: TWO OF A KIND?
Wietske Kievit, MSc, Eddy M.M. Adang, PhD, Jos Hendrikx, BSc, Piet L.C.M. Van Riel, PhD, MD
*INVESTIGATING POSSIBLE OUTCOME DEPENDENCY OF SCALE RECALIBRATION
Wietske Kievit, MSc, Eddy M.M. Adang, PhD, Jos Hendrikx, BSc, Piet L.C.M. Van Riel, PhD, MD
A SIMULATION MODEL OF THE POTENTIAL IMPACT OF AN INFLUENZA PANDEMIC ON THE PREGNANT POPULATION IN ALLEGHENY COUNTY
Richard H. Beigi, MD, MSc., Bruce Y. Lee, MD, MBA
*MULTI-CRITERIA DECISION ANALYSES FOR A CHILDBIRTH AFTER CESAREAN DECISION
Poonam Sharma, Karen B. Eden, James G. Dolan, Holly B. Jimison, Jeanne Marie Guise
TRANSLATING RESEARCH INTO PRACTICE: DIFFUSION OF BREAST CANCER DECISION AIDS
Ekeoma Uzogara, BS, Karen R. Sepucha, PhD
*ELECTRONIC PRESCRIBING IN PRIMARY CARE: A CASE STUDY OF PROCESS FAILURE AND ITS IMPACT ON TECHNOLOGY UTILIZATION
YiChin Lin, MS, Keith T. Kanel, MD, MHCM, Rema Padman, PhD
THE CONSEQUENCES OF GENERIC COMPETITION ON THE COST-EFFECTIVENESS OF PRIMARY CARDIOVASCULAR PREVENTION WITH STATINS OR ANTIHYPERTENSIVES
Torbjørn Wisløff, M.Sc., Ole Frithjof Norheim, PhD, Sigrun Halvorsen, PhD, Randi Selmer, PhD, Ivar Sønbø Kristiansen, MD PhD MPH
MODEL-BASED ECONOMIC EVALUATION OF STRATEGIES TO IMPROVE TUBERCULOSIS CONTROL IN SOUTH AFRICA
Stephen Resch, PhD, Joshua A. Salomon, PhD, Megan Murray, MD, DPH, Milton C. Weinstein, PhD
*BREAST CANCER CHEMOPREVENTION WITH TAMOXIFEN OR RALOXIFENE: A DECISION ANALYSIS
Wendy M. Golden, MD, MPH, John B. Wong, MD
DO MEN DISCONTINUE PROSTATE CANCER SCREENING WHEN THEIR LIFE EXPECTANCY DECLINES?
Yalin Aileen Huang, MS, doctoral, st, David H. Howard, PhD
*A QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB
Joel P. Thompson, MPH, Katia Noyes, PhD, E. Ray Dorsey, MD, MBA, Steven Schwid, MD, Robert G. Holloway, MD, MPH
DISTRIBUTION OF DECISION AIDS IN PRACTICE-BASED RESEARCH NETWORK SITES: PROBLEMS AND SOLUTIONS
Catherine R. Cheung, MA, Susana Mendoza, Dustin M. Lillie, William J. Sieber
POTENTIAL SYSTEMATIC BIAS IN THE ESTIMATION OF COST-EFFECTIVENESS THAT RESULT FROM USING NON DISEASE-SPECIFIC COSTS: DEMONSTRATION WITH A POPULATION-BASED DIABETES AND MATCHED NON-DIABETES COHORT IN THE PROVINCE OF ONTARIO
Robert Hopkins, MA, Daria J. O'Reilly, PhD, MSc, Gord Blackhouse, MBA, Jean-Eric Tarride, PhD, MA, James M. Bowen, BScPhm, MSc, Kaitryn Campbell, MLIS, Lisa Patterson, BA, Ron Goeree, MA
NUMERACY AND INFORMED MEDICAL DECISION MAKING
Valerie Reyna, PhD, Wendy Nelson, PhD, Paul K. J. Han, MD, MA, MPH
*SCREENNG FOR HEPATITIS C: WHEN AND HOW OFTEN
Daniel Faissol, BS, H. Eser Kirkizlar, BS, Paul M. Griffin, PhD, Julie L. Swann, PhD
FINDING KEY THRESHOLDS IN PATIENT UTILITIES USING ROBUST OPTIMIZATION
Joseph W. Norman, MD, PhD
IMPACT OF HPV VACCINE DURATION AND EFFICACY ON COST-EFFECTIVENESS OF VACCINATION IN VIETNAM
Jane J. Kim, PhD, Katie Kobus, BA, Meredith O'Shea, MA, Sue J. Goldie, MD, MPH
*CARDIOVASCULAR DISEASE RISK ASSOCIATED WITH AROMATASE INHIBITOR VS. TAMOXIFEN TREATMENT IN BREAST CANCER PATIENTS
Elizabeth N. Ssemanda, MMSc, Nananda F. Col, MD, MPH, MPP, Mark D. Schleinitz, MD, MS, George Papandonatos, PhD
A NEW MODEL OF CARDIOVACULAR DISEASE DEATH, GIVING INDIVIDUALISED RISK ESTIMATES: AN EVALUATION USING THE WHICKHAM STUDY
Christopher J. Martin, MB, ChB, FRCGP,, Mark Vanderpump, Joyce French
PATIENT RISK ASSESSMENTS AND TREATMENT PREDICTIONS ARE POOR AT THE TIME OF PROSTATE BIOPSY
William Dale, MD, PhD, Joshua Hemmerich, PhD, Anirban Basu, PhD, David O. Meltzer, MD, PhD
WHAT DOES IT MEAN TO HAVE REASONABLE SUSPICION OF CHILD ABUSE?
Benjamin H. Levi, MD, PhD
DO CONSUMERS RESPOND TO NEW EVIDENCE OF INEFFICACY? AN ANALYSIS OF SALES DATA BEFORE AND AFTER PUBLICATION OF MAJOR CLINICAL TRIALS OF DIETARY SUPPLEMENTS
Jon C. Tilburt, MD, MPH
*LIQUID-BASED CYTOLOGY TECHNIQUES FOR CERVICAL CANCER SCREENING: A SYSTEMATIC REVIEW OF TEST PERFORMANCE CHARACTERISTICS
Ba Pham, MSc, Murray Krahn, MD, MSc, Meg McLachlin, MD, Barry Rosen, MD, Beate Sander, RN, MBA, MEcDev, Paul Grootendorst, PhD, George Tomlinson, PhD, Ava John-Baptiste, MHSc, Maraki Frikemerid, MSc, Maggie Hong Chen, MMath, Gloria Woo, MSc, Andrea Anonychuk, MSc, Steven M. Carcone, MSc, Holly Witterman, MSc, Wendong Chen, MD, Karen Liu, BA, Margaret Sampson, PhD, (Candidate), Andrea C. Tricco, MSc
USING A MODELING APPROACH TO EVALUATE THE IMPACT OF DISPARITIES IN CANCER SCREENING
Karen M. Kuntz, Zhiying Zhao, BA, Sue J. Goldie, MD, MPH
*HOW TO MISLEAD WITHOUT LYING: SELECTIVE PRESENTATION OF RESULTS
Gabriel K. Silverman, MS, Britta Anderson, MS, George Loewenstein, PhD, Stanley Zinberg, MD, MS, Jay Schulkin, PhD
EXPANDED NEWBORN SCREENING: THE EFFECT OF PREFERENCES FOR FALSE POSITIVE TEST RESULTS AND DIETARY TREATMENTS ON COST-EFFECTIVENESS
Lisa A. Prosser, PhD, Joey Kong, PhD, Donna Rusinak, Susan E. Waisbren, PhD

See more of The 29th Annual Meeting of the Society for Medical Decision Making (October 20-24, 2007)


Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)